Donor After Circulatory Death Heart CAP Trial

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

December 21, 2021

Study Completion Date

June 29, 2022

Conditions
Heart Transplant
Interventions
DEVICE

Transplant

To enable continued clinical access to DCD heart transplantation in the U.S. and to continue to collect additional data on the performance of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation.

Trial Locations (25)

10032

Nyph/Cumc, New York

10467

Montefiore, The Bronx

10595

Westchester Medical Center, Valhalla

23219

Virginia Commonwealth University, Richmond

23502

Sentara, Norfolk

27710

Duke University, Durham

30322

Emory University Hospital, Atlanta

32224

Mayo Clinic Florida, Jacksonville

32803

AdventHealth Orlando, Orlando

33606

Tampa General Hospital, Tampa

37212

Vanderbilt University Medical Center, Nashville

46260

St. Vincent Cardiovascular Research Institute, Indianapolis

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

53792

University of Wisconsin, Madison

55407

Minneapolis Heart Institute, Minneapolis

60208

Northwestern University, Evanston

68198

University of Nebraska Medical Center, Omaha

90048

Cedars Sinai, Los Angeles

92037

University of California San Diago, La Jolla

94304

Stanford University, Palo Alto

06510

Yale New Haven Hospital, New Haven

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

55455-0213

University of Minnesota, Minneapolis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT04615182 - Donor After Circulatory Death Heart CAP Trial | Biotech Hunter | Biotech Hunter